Burzynski Research Institute (BZYR) Cash from Operations (QoQ) (2011 - 2025)
Burzynski Research Institute (BZYR) Cash from Operations (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Burzynski Research Institute | 1.31 Mn | 1.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | -767.28% |
| Aug 31, 2025 | -93.12% |
| May 31, 2025 | -106.93% |
| Feb 28, 2025 | 179.68% |
| Nov 30, 2024 | -501.14% |
| Aug 31, 2024 | -148.78% |
| May 31, 2024 | 56.74% |
| Feb 29, 2024 | 31.56% |
| Nov 30, 2023 | -67.90% |
| Aug 31, 2023 | -83.40% |
| May 31, 2023 | 10.88% |
| Feb 28, 2023 | -53.97% |
| Nov 30, 2022 | 46.84% |
| Aug 31, 2022 | -128.75% |
| May 31, 2022 | 32.65% |
| Feb 28, 2022 | 38.94% |
| Nov 30, 2021 | -8.86% |
| Aug 31, 2021 | -3.52% |
| May 31, 2021 | -69.81% |
| Feb 28, 2021 | 59.85% |